ABGSC acted as joint bookrunner in connection with the USD 65m (SEK 567m) directed issue of shares in Saniona

On Monday 10 August 2020, Saniona AB (publ) (“Saniona”) announced the successful completion of a directed share issue, issuing 30.7m new shares at a subscription price of USD 2.12 (SEK 18.50), resulting in gross proceeds of USD 65m (SEK 567m). The proceeds will allow Saniona to continue the advancement of its late-stage clinical trials with Tesomet in two rare eating disorders, hypothalamic obesity and Prader Willi
Syndrome, as well as to build its US-based organisation in support of these programs. The directed share issue was led by RA Capital Management with participation from Pontifax Venture Capital and New Leaf Venture Partners among other US and international healthcare investors as well as the Second Swedish National Pension Fund (AP2), the Third Swedish National Pension Fund (AP3), the Fourth Swedish National Pension Fund (AP4) and Arctic Aurora LifeScience.